These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 22564834)
1. Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168del. Yi H; Kim K; Cho KH; Jung O; Kim HS Antimicrob Agents Chemother; 2012 Jul; 56(7):4005-8. PubMed ID: 22564834 [TBL] [Abstract][Full Text] [Related]
2. Deletion mutations conferring substrate spectrum extension in the class A β-lactamase. Hwang J; Cho KH; Song H; Yi H; Kim HS Antimicrob Agents Chemother; 2014 Oct; 58(10):6265-9. PubMed ID: 25049254 [TBL] [Abstract][Full Text] [Related]
3. Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen. Papp-Wallace KM; Becka SA; Taracila MA; Zeiser ET; Gatta JA; LiPuma JJ; Bonomo RA Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872073 [TBL] [Abstract][Full Text] [Related]
4. Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution. Yi H; Cho KH; Cho YS; Kim K; Nierman WC; Kim HS PLoS One; 2012; 7(5):e37585. PubMed ID: 22629423 [TBL] [Abstract][Full Text] [Related]
6. Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans. Becka SA; Zeiser ET; Marshall SH; Gatta JA; Nguyen K; Singh I; Greco C; Sutton GG; Fouts DE; LiPuma JJ; Papp-Wallace KM Diagn Microbiol Infect Dis; 2018 Nov; 92(3):253-258. PubMed ID: 29983287 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance. Chirakul S; Norris MH; Pagdepanichkit S; Somprasong N; Randall LB; Shirley JF; Borlee BR; Lomovskaya O; Tuanyok A; Schweizer HP Sci Rep; 2018 Jul; 8(1):10652. PubMed ID: 30006637 [TBL] [Abstract][Full Text] [Related]
8. Functional characterization of OXA-57, a class D beta-lactamase from Burkholderia pseudomallei. Keith KE; Oyston PC; Crossett B; Fairweather NF; Titball RW; Walsh TR; Brown KA Antimicrob Agents Chemother; 2005 Apr; 49(4):1639-41. PubMed ID: 15793160 [TBL] [Abstract][Full Text] [Related]
9. Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants. Papp-Wallace KM; Taracila MA; Gatta JA; Ohuchi N; Bonomo RA; Nukaga M J Biol Chem; 2013 Jun; 288(26):19090-102. PubMed ID: 23658015 [TBL] [Abstract][Full Text] [Related]
10. Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition. Tribuddharat C; Moore RA; Baker P; Woods DE Antimicrob Agents Chemother; 2003 Jul; 47(7):2082-7. PubMed ID: 12821450 [TBL] [Abstract][Full Text] [Related]
12. Genetic and functional variability of AmpC-type β-lactamases from Acinetobacter baumannii. Rodríguez-Martínez JM; Poirel L; Nordmann P Antimicrob Agents Chemother; 2010 Nov; 54(11):4930-3. PubMed ID: 20713667 [TBL] [Abstract][Full Text] [Related]
13. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients. Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560 [TBL] [Abstract][Full Text] [Related]
14. High adaptability of the omega loop underlies the substrate-spectrum-extension evolution of a class A β-lactamase, PenL. Yi H; Choi JM; Hwang J; Prati F; Cao TP; Lee SH; Kim HS Sci Rep; 2016 Nov; 6():36527. PubMed ID: 27827433 [TBL] [Abstract][Full Text] [Related]
15. Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases. Degrossi JJ; Merino C; Isasmendi AM; Ibarra LM; Collins C; Bo NE; Papalia M; Fernandez JS; Hernandez CM; Papp-Wallace KM; Bonomo RA; Vazquez MS; Power P; Ramirez MS Curr Microbiol; 2019 Apr; 76(4):485-494. PubMed ID: 30783798 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems. Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233 [TBL] [Abstract][Full Text] [Related]
18. Mutations in ArgS Arginine-tRNA Synthetase Confer Additional Antibiotic Tolerance Protection to Extended-Spectrum-β-Lactamase-Producing Burkholderia thailandensis. Yi H; Park J; Cho KH; Kim HS Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205346 [TBL] [Abstract][Full Text] [Related]
19. Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei. Randall LB; Dobos K; Papp-Wallace KM; Bonomo RA; Schweizer HP Antimicrob Agents Chemother; 2015 Dec; 60(3):1509-14. PubMed ID: 26711764 [TBL] [Abstract][Full Text] [Related]
20. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop. Winkler ML; Papp-Wallace KM; Bonomo RA J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]